🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
144,67 USD
Máx. histórico
156,45
70 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-7,53%
Rango 52 semanas
82,01 – 156,92
Variación hoy
-2,49%
Cierre anterior
148,36
Rango de hoy
143,47 – 147,62
Volumen hoy
8.862.415
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,42%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 146,13 (puede no estar actualizado)
- Dividend yield
- 2,29% (puede no estar actualizado)
- Precio objetivo analistas
- 160,29 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 16 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/02/1972 | 1,81 | 1,83 | 1,81 | 1,82 | +0,36% | 1,28% | 1.222.387 |
| 03/02/1972 | 1,80 | 1,84 | 1,80 | 1,81 | +2,05% | 2,22% | 1.826.035 |
| 02/02/1972 | 1,74 | 1,78 | 1,74 | 1,78 | +2,78% | 2,10% | 565.920 |
| 01/02/1972 | 1,72 | 1,73 | 1,72 | 1,73 | +0,28% | 0,96% | 701.741 |
| 31/01/1972 | 1,73 | 1,74 | 1,72 | 1,72 | -0,19% | 1,15% | 1.177.114 |
| 28/01/1972 | 1,72 | 1,73 | 1,72 | 1,73 | +0,58% | 0,58% | 1.373.299 |
| 27/01/1972 | 1,70 | 1,72 | 1,70 | 1,72 | +1,57% | 0,97% | 1.456.301 |
| 26/01/1972 | 1,69 | 1,69 | 1,68 | 1,69 | -0,19% | 0,98% | 860.198 |
| 25/01/1972 | 1,66 | 1,70 | 1,66 | 1,69 | +1,79% | 2,29% | 822.470 |
| 24/01/1972 | 1,66 | 1,67 | 1,66 | 1,66 | +0,00% | 0,70% | 784.742 |
| 21/01/1972 | 1,66 | 1,67 | 1,66 | 1,66 | +0,00% | 0,79% | 784.742 |
| 20/01/1972 | 1,68 | 1,68 | 1,66 | 1,66 | -1,96% | 1,38% | 1.418.573 |
| 19/01/1972 | 1,71 | 1,71 | 1,69 | 1,70 | -0,77% | 1,06% | 1.124.294 |
| 18/01/1972 | 1,71 | 1,71 | 1,71 | 1,71 | +0,39% | 0,19% | 671.558 |
| 17/01/1972 | 1,69 | 1,71 | 1,69 | 1,70 | +0,49% | 1,17% | 1.260.115 |
| 14/01/1972 | 1,69 | 1,70 | 1,69 | 1,69 | +0,30% | 0,30% | 430.099 |
| 13/01/1972 | 1,69 | 1,69 | 1,67 | 1,69 | -1,16% | 1,37% | 1.131.840 |
| 12/01/1972 | 1,72 | 1,72 | 1,71 | 1,71 | -0,58% | 0,58% | 550.829 |
| 11/01/1972 | 1,71 | 1,72 | 1,71 | 1,72 | +0,87% | 0,78% | 709.286 |
| 10/01/1972 | 1,71 | 1,71 | 1,70 | 1,70 | -0,48% | 0,77% | 633.830 |
| 07/01/1972 | 1,71 | 1,72 | 1,70 | 1,71 | +0,09% | 1,45% | 837.562 |
| 06/01/1972 | 1,72 | 1,74 | 1,70 | 1,71 | -0,29% | 2,31% | 1.478.938 |
| 05/01/1972 | 1,72 | 1,74 | 1,72 | 1,72 | +1,17% | 1,16% | 1.509.120 |
| 04/01/1972 | 1,67 | 1,70 | 1,67 | 1,70 | +2,20% | 1,59% | 603.648 |
| 03/01/1972 | 1,64 | 1,67 | 1,64 | 1,66 | +1,01% | 1,61% | 769.651 |
| 31/12/1971 | 1,64 | 1,65 | 1,64 | 1,64 | +0,61% | 0,61% | 445.190 |
| 30/12/1971 | 1,62 | 1,64 | 1,62 | 1,63 | +0,61% | 1,63% | 648.922 |
| 29/12/1971 | 1,64 | 1,65 | 1,62 | 1,62 | -1,20% | 1,61% | 996.019 |
| 28/12/1971 | 1,65 | 1,65 | 1,63 | 1,64 | -0,41% | 1,01% | 852.653 |
| 27/12/1971 | 1,66 | 1,67 | 1,64 | 1,65 | -0,79% | 1,69% | 822.470 |